Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 917478

Significance of surgery for prognosis of GIST in cohort from transitional healthcare settings


Zovak, Mario; Boban, Marko; Boban, Ljubica; Cicek, Silvio; Madzar, Zrinko; Belev, Borislav; Tomas, Davor
Significance of surgery for prognosis of GIST in cohort from transitional healthcare settings // International Journal of Surgery, 12 (2014), 11; 1167-1171 doi:10.1016/j.ijsu.2014.07.275 (međunarodna recenzija, članak, ostalo)


CROSBI ID: 917478 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Significance of surgery for prognosis of GIST in cohort from transitional healthcare settings

Autori
Zovak, Mario ; Boban, Marko ; Boban, Ljubica ; Cicek, Silvio ; Madzar, Zrinko ; Belev, Borislav ; Tomas, Davor

Izvornik
International Journal of Surgery (1743-9191) 12 (2014), 11; 1167-1171

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, ostalo

Ključne riječi
Gastrointestinal stromal tumor (GIST), Surgical treatment, Complete resection, Ki-67, Adjuvant treatment, Imatinib

Sažetak
OBJECTIVE: Despite significant improvement in survival of gastrointestinal stromal tumors (GIST) due to use of tyrosine kinase inhibitors, surgery still represents the important part of clinical management. The aim of our study was to retrospectively analyze prognosis of GIST depending on the success of surgical treatments and utilization of chemotherapy in transitional country with relatively limited resources. METHODS: cohort of consecutive patients operated for GIST in tertiary medical center, within time frame 1999-2012. RESULTS: 54 patients, in age range 20-85 years (63.3 ± 14.7), male to female ratio 28 (51.9%):26 (48.1%), respectively. Complete excision with clean resection margins (R0) was obtained in 44 (81.5%)of total patients i.e. 44/47 (93.6%) of localized GISTs. Mean follow up was 3.9 ± 3.3 years and 19 patients (35.2%) received imatinib. Rate of overall survival was 40 (74.1%), disease-free survival 31 (57.4%) and 20 (37.0%) experienced recidivism. Follow-up parameters showed significant difference in connection with utilization of imatinib, completeness of resection and existence of metastatic disease (all p < 0.05). ROC analyzes revealed critical value of Ki-67 > 9% as significant predictor of long-term mortality ; sensitivity 64.3% [95%CI = 35.1-87.2] ; specificity 75.0% [58.8-87.3] ; (AUC = 0.693 ; p = 0.049). CONCLUSION: Rate of complete resections in studied sample of patients from transitional background was overall peer comparable with reports from the developed countries. On the other hand, relatively dominant prognostic position of surgical treatments might be consequence of limited utilization of adjuvant treatment with tyrosine kinase inhibitors.

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti



POVEZANOST RADA


Ustanove:
Medicinski fakultet, Rijeka,
Medicinski fakultet, Zagreb,
KBC "Sestre Milosrdnice",
Medicinski fakultet, Osijek

Profili:

Avatar Url Borislav Belev (autor)

Avatar Url Davor Tomas (autor)

Avatar Url Marko Boban (autor)

Avatar Url Zrinko Madžar (autor)

Avatar Url Mario Zovak (autor)

Poveznice na cjeloviti tekst rada:

doi www.journal-surgery.net

Citiraj ovu publikaciju:

Zovak, Mario; Boban, Marko; Boban, Ljubica; Cicek, Silvio; Madzar, Zrinko; Belev, Borislav; Tomas, Davor
Significance of surgery for prognosis of GIST in cohort from transitional healthcare settings // International Journal of Surgery, 12 (2014), 11; 1167-1171 doi:10.1016/j.ijsu.2014.07.275 (međunarodna recenzija, članak, ostalo)
Zovak, M., Boban, M., Boban, L., Cicek, S., Madzar, Z., Belev, B. & Tomas, D. (2014) Significance of surgery for prognosis of GIST in cohort from transitional healthcare settings. International Journal of Surgery, 12 (11), 1167-1171 doi:10.1016/j.ijsu.2014.07.275.
@article{article, author = {Zovak, Mario and Boban, Marko and Boban, Ljubica and Cicek, Silvio and Madzar, Zrinko and Belev, Borislav and Tomas, Davor}, year = {2014}, pages = {1167-1171}, DOI = {10.1016/j.ijsu.2014.07.275}, keywords = {Gastrointestinal stromal tumor (GIST), Surgical treatment, Complete resection, Ki-67, Adjuvant treatment, Imatinib}, journal = {International Journal of Surgery}, doi = {10.1016/j.ijsu.2014.07.275}, volume = {12}, number = {11}, issn = {1743-9191}, title = {Significance of surgery for prognosis of GIST in cohort from transitional healthcare settings}, keyword = {Gastrointestinal stromal tumor (GIST), Surgical treatment, Complete resection, Ki-67, Adjuvant treatment, Imatinib} }
@article{article, author = {Zovak, Mario and Boban, Marko and Boban, Ljubica and Cicek, Silvio and Madzar, Zrinko and Belev, Borislav and Tomas, Davor}, year = {2014}, pages = {1167-1171}, DOI = {10.1016/j.ijsu.2014.07.275}, keywords = {Gastrointestinal stromal tumor (GIST), Surgical treatment, Complete resection, Ki-67, Adjuvant treatment, Imatinib}, journal = {International Journal of Surgery}, doi = {10.1016/j.ijsu.2014.07.275}, volume = {12}, number = {11}, issn = {1743-9191}, title = {Significance of surgery for prognosis of GIST in cohort from transitional healthcare settings}, keyword = {Gastrointestinal stromal tumor (GIST), Surgical treatment, Complete resection, Ki-67, Adjuvant treatment, Imatinib} }

Časopis indeksira:


  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE


Citati:





    Contrast
    Increase Font
    Decrease Font
    Dyslexic Font